Business Context and Reporting Period
This Form 8-K is filed by Lion Biotechnologies, Inc. (not IOVANCE BIOTHERAPEUTICS, INC.) on May 9, 2016. The filing serves to announce the company's financial results for the first quarter ended March 31, 2016. The detailed results are contained in a press release furnished as Exhibit 99.1 and incorporated by reference.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being available in the attached press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms the issuance of the Q1 2016 results announcement.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, specific risks, contingencies, or unusual items. These details are presumed to be within the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Verify the correct registrant name is Lion Biotechnologies, Inc., as the input metadata incorrectly listed IOVANCE BIOTHERAPEUTICS, INC.
- Review Exhibit 99.1 (the May 9, 2016 press release) to obtain actual Q1 2016 financial figures.
- Confirm the company's current operational status, as Lion Biotechnologies has undergone significant corporate changes since 2016.